Bloomberg Law
May 14, 2018, 6:42 PM

DNA Testing Company 23andMe Battles It Out With

Dana A. Elfin
Dana A. Elfin

A patent and trademark tiff is brewing between 23andMe Inc. and, the top two competitors in the burgeoning consumer genetic testing market.

23andMe’s suit says’s sales of its AncestryDNA kits infringes 23andMe’s U.S. Patent No. 8,463,554 covering finding relatives in a database. The company also accuses of misleadingly comparing its services with 23andMe’s services.

The consumer market for genetic testing is big business, and the services are becoming more popular as consumers get more comfortable using them. In 2017, the consumer DNA testing market was valued at $99 million, and it could hit $310 million by 2022, ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.